IHS Chemical Week

People & Business :: M&A

Moberg Pharma acquires three OTC brands in the US from Bayer HealthCare

5:57 AM MST | December 6, 2013 | Natasha Alperowicz

Moberg Pharma (Stockholm) announced today that it has signed a deal to acquire three well-established OTC brands in the United States from Bayer HealthCare for 32 million Swedish kronor ($4.8 million) in cash. Total annual sales for the brands are approximately SK20 million. The transaction is expected to close before the end of 2013.    The acquired portfolio includes Domeboro, a topical astringent used for relieving itch and minor skin irritations; Vanquish, an internal analgesic; and Fergon, an iron supplement. The brands will be sold through...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa